| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Heyman Richard A. serves as a Director at ORIC and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 58 sells. Those positions are worth an estimated $4.3M at current prices.
Historically, Heyman Richard A.'s trades have earned a strong insider score of 74/100 across 37 rated trades. Over a 12-month horizon, 77.1% of those trades were profitable, with an average 12-month return of +35.1%.
The biggest single holding is ORIC (~$2.8M) as Director. The recent filings there lean toward selling, a net 31,028 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2024 | ELVN Enliven Therapeutics, Inc. | Director | Sell | 1,270 | $24.80 | $31,496.76 | -0.9% | +10.6% | -13.7% | |
| Jun 17, 2024 | ELVN Enliven Therapeutics, Inc. | Director | Sell | 1,270 | $21.48 | $27,277.95 | -0.9% | +3.8% | +1.1% | |
| May 16, 2024 | ELVN Enliven Therapeutics, Inc. | Director | Sell | 1,270 | $23.74 | $30,149.67 | -0.9% | -8.4% | -29.2% | |
| Apr 15, 2024 | ELVN Enliven Therapeutics, Inc. | Director | Sell | 6,964 | $24.11 | $167,887.52 | -2.2% | +25.9% | -14.5% | |
| Mar 19, 2024 | ELVN Enliven Therapeutics, Inc. | Director | Sell | 1,270 | $14.50 | $18,418.68 | -0.9% | +22.9% | +19.1% | |
| Feb 15, 2024 | ELVN Enliven Therapeutics, Inc. | Director | Sell | 1,270 | $17.42 | $22,117.43 | -0.9% | +38.7% | +25.3% | |
| Jan 30, 2024 | ELVN Enliven Therapeutics, Inc. | Director | Sell | 1,270 | $16.41 | $20,839.56 | -0.9% | +9.3% | +28.1% | |
| Dec 22, 2023 | ELVN Enliven Therapeutics, Inc. | Director | Sell | 216 | $13.00 | $2,808.00 | - | +21.6% | +51.3% | |
| Dec 20, 2023 | ELVN Enliven Therapeutics, Inc. | Director | Sell | 4,280 | $13.02 | $55,727.05 | -1.3% | +43.9% | +87.6% | |
| Sep 15, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 1,388 | $25.04 | $34,759.74 | -0.3% | -52.1% | -86.6% |